FindTrial
Sign In

The application value of cerebrospinal fluid cytology, secondary-generation sequencing, EEG and magnetic resonance in patients with encephalitis,

The application value of cerebrospinal fluid cytology, secondary-generation sequencing, EEG and magnetic resonance in patients with encephalitis,

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100043299
Enrollment
Unknown
Registered
2021-02-09
Start date
2021-03-01
Completion date
Unknown
Last updated
2021-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Encephalitis

Interventions

case series:Nil

Sponsors

Shenzhen Baoan Shiyan People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients who have core symptoms of encephalitis, including fever, headache, epileptic seizures, mental and behavioral disorders, cognitive and language disorders, and impaired consciousness. They will be diagnosed and treated in the Department of Neurology, Shenzhen Baoan Shiyan People's Hospital from March 2020 to November 2020.

Exclusion criteria

Exclusion criteria: Patients who do not agree to have EEG, MRI, CSF cytology, and CSF etiology secondary-generation sequenced during.

Design outcomes

Primary

MeasureTime frame
Cerebrospinal fluid cytology;Electroenphalogram;The second generation sequencing;Magnetic Resonance Imaging;—

Countries

China

Contacts

Public ContactPiao yushun

Shenzhen Baoan Shiyan People's Hospital

pys0119jp@126.com+86 13570889488

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026